×
About 19,886 results

ALLMedicine™ HIV Center

Research & Reviews  9,699 results

HIV Care Engagement Among Justice-Involved and Substance Using People of Puerto Rican O...
https://doi.org/10.1007/s10903-021-01191-x
Journal of Immigrant and Minority Health; Wiersema JJ, Teixeira PA et. al.

May 4th, 2021 - Persons living with diagnosed HIV (PLWDH) are overrepresented in correctional settings, as are Latinx including those of Puerto Rican (PR) origin. Little is known about this population's HIV care engagement after incarceration. Semi-structured int...

Understanding and addressing privacy and confidentiality concerns associated with the p...
https://doi.org/10.1080/09540121.2021.1921104
AIDS Care; Marellapudi A, Hussen SA et. al.

May 3rd, 2021 - Less than half the people with HIV (PLWH) in the United States (US) are retained in HIV care, underscoring the importance of novel reengagement and retention strategies. Mobile HIV clinics (MHCs) are one such strategy, but privacy and confidential...

Factors associated with incidence of stroke and heart failure among people living with ...
https://doi.org/10.1111/jch.14255
Journal of Clinical Hypertension (Greenwich, Conn.); Sarfo FS, Norman B et. al.

May 3rd, 2021 - People living with HIV (PLWH) have a two-fold higher risk of cardiovascular diseases (CVDs) compared with HIV-negative populations. Although 70% of the global HIV population reside in Africa, data on CVD outcomes among PLWH are scarce. We seek to ...

Evaluation of an integrated treatment to address smoking cessation and anxiety/depressi...
https://doi.org/10.1016/j.cct.2021.106420
Contemporary Clinical Trials; Garey L, Wirtz MR et. al.

May 2nd, 2021 - Interventions that target anxiety/depressive symptoms in the context of smoking treatment have shown promise irrespective of psychiatric diagnosis. Yet, these tailored treatments are largely absent for persons who smoke and are living with HIV (SL...

Recreational Drug Use in People Living with HIV in Spain: Factors Associated with Drug ...
https://doi.org/10.1007/s10461-021-03271-3 10.1097/QAD.0b013e32835cae9c 10.1186/s12981-020-00279-y 10.1371/journal.pone.0211252 10.1016/S1575-0973(01)70014-1 10.1111/j.1360-0443.2011.03759.x 10.1016/S2352-3018(14)70001-3 10.1089/apc.2017.0263 10.3389/fmicb.2015.00690 10.3109/16066350902770433 10.1080/10826080802484702 10.1186/s12954-017-0143-4 10.1093/jurban/jtg127 10.1016/j.drugalcdep.2017.08.036 10.1093/eurpub/ckp091 10.1111/hiv.12574 10.1097/01.aids.0000180794.27896.fb 10.1177/003335490612100205 10.1007/s10461-008-9403-3 10.2105/AJPH.2005.072249 10.1136/sextrans-2013-051195 10.1136/bmjopen-2016-014105 10.1016/j.drugalcdep.2007.11.010 10.1186/s12889-019-7747-4 10.1097/00126334-200107010-00006 10.1097/00002030-200203290-00012 10.1097/QAD.0b013e3282f3cc21 10.1016/S2352-3018(20)30202-2 10.1371/journal.pone.0084276 10.1080/09540121.2012.672718 10.1007/s10461-013-0463-7 10.1089/apc.2007.0122 10.1136/sti.79.1.59 10.1037/0278-6133.19.2.124 10.1089/108729104323076025 10.1023/b:ejep.0000032353.03967.ef 10.1007/s10461-008-9489-7 10.1007/s10461-016-1297-x 10.1097/ADM.0000000000000403 10.1037/hea0000207 10.1111/hiv.12690 10.1016/j.addbeh.2012.09.005 10.1177/0706743716664884 10.1371/journal.pone.0195185 10.1111/add.14892 10.1186/PREACCEPT-1453408941291432 10.1007/s40271-013-0009-0 10.1017/s0033291700021644 10.1016/j.medcli.2013.02.037 10.1038/s41598-018-26413-5 10.1136/sextrans-2019-054040 10.1186/s12889-019-7747-4 10.1136/postgradmedj-2012-131428 10.1080/09540121.2017.1327646 10.1016/S2352-3018(15)00018-1 10.1097/00002030-200106150-00015 10.1086/650537 10.1007/s10865-020-00148-z 10.1086/377558 10.1016/s0376-8716(00)00228-3 10.1016/j.drugpo.2016.01.017 10.1186/1471-2458-8-405 10.1001/jama.285.18.2355 10.1097/00126334-200311010-00012
AIDS and Behavior; Castro-Granell V, Garin N et. al.

May 1st, 2021 - We analysed the impact of recreational drug use (RDU) on different outcomes in people living with HIV (PLHIV). A multicentre retrospective cohort study was performed with two cohorts of PLHIV included: people using recreational drugs (PURD) vs. pe...

see more →

Guidelines  31 results

HIV, schizophrenia, and all-cause mortality
https://www.sciencedirect.com/science/article/abs/pii/S0920996419301537?via%3Dihub
Schizophrenia Research;

Jun 26th, 2019 - Schizophrenia is a severe mental illness with important implications for morbidity and mortality. This population-based cohort study examined the impact of schizophrenia diagnoses on all-cause mortality among a sample of people living with HIV (PL...

Rapid initiation of antiretroviral therapy at HIV diagnosis: definition, process, knowledge gaps
https://onlinelibrary.wiley.com/doi/abs/10.1111/hiv.12708
Boyd,M.,et al

Feb 5th, 2019 - nitiating antiretroviral therapy (ART) as early as the day of HIV diagnosis is a strategy of increasing global interest to control the HIV epidemic and optimize the health of people living with HIV (PLWH). No detrimental effects of rapid‐start ART...

AIDS-Related Kaposi Sarcoma, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
http://www.jnccn.org/content/17/2/171.full
Reid. E.,et al

Jan 31st, 2019 - As treatment of HIV has improved, people living with HIV (PLWH) have experienced a decreased risk of AIDS and AIDS-defining cancers (non-Hodgkin's lymphoma, Kaposi sarcoma, and cervical cancer), but the risk of Kaposi sarcoma in PLWH is still elev...

Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Exposed and H...
https://aidsinfo.nih.gov/guidelines/html/5/pediatric-opportunistic-infection/0
Office of AIDS Research Advisory Council

Jan 8th, 2019 - This report updates the last version of the Guidelines for the Prevention and Treatment of Opportunistic Infections (OIs) in HIV-Exposed and HIV-Infected Children, published in 2013. 1 These guidelines are intended for use by clinicians and other h.

Diagnosis, prevention, and treatment of bone fragility in people living with HIV: a pos...
https://doi.org/10.1007/s00198-018-4794-0
Osteoporosis International : a Journal Established as Res... Biver E, Calmy A et. al.

Jan 3rd, 2019 - Life expectancy of people living with HIV (PLWH) is reaching similar length as in the general population. Accordingly, age-related comorbidities, including osteoporosis, are increasing. Fracture risk is higher and increases approximately 10 years ...

see more →

Drugs  11 results see all →

Clinicaltrials.gov  9,923 results

HIV Care Engagement Among Justice-Involved and Substance Using People of Puerto Rican O...
https://doi.org/10.1007/s10903-021-01191-x
Journal of Immigrant and Minority Health; Wiersema JJ, Teixeira PA et. al.

May 4th, 2021 - Persons living with diagnosed HIV (PLWDH) are overrepresented in correctional settings, as are Latinx including those of Puerto Rican (PR) origin. Little is known about this population's HIV care engagement after incarceration. Semi-structured int...

Understanding and addressing privacy and confidentiality concerns associated with the p...
https://doi.org/10.1080/09540121.2021.1921104
AIDS Care; Marellapudi A, Hussen SA et. al.

May 3rd, 2021 - Less than half the people with HIV (PLWH) in the United States (US) are retained in HIV care, underscoring the importance of novel reengagement and retention strategies. Mobile HIV clinics (MHCs) are one such strategy, but privacy and confidential...

Factors associated with incidence of stroke and heart failure among people living with ...
https://doi.org/10.1111/jch.14255
Journal of Clinical Hypertension (Greenwich, Conn.); Sarfo FS, Norman B et. al.

May 3rd, 2021 - People living with HIV (PLWH) have a two-fold higher risk of cardiovascular diseases (CVDs) compared with HIV-negative populations. Although 70% of the global HIV population reside in Africa, data on CVD outcomes among PLWH are scarce. We seek to ...

Evaluation of an integrated treatment to address smoking cessation and anxiety/depressi...
https://doi.org/10.1016/j.cct.2021.106420
Contemporary Clinical Trials; Garey L, Wirtz MR et. al.

May 2nd, 2021 - Interventions that target anxiety/depressive symptoms in the context of smoking treatment have shown promise irrespective of psychiatric diagnosis. Yet, these tailored treatments are largely absent for persons who smoke and are living with HIV (SL...

Recreational Drug Use in People Living with HIV in Spain: Factors Associated with Drug ...
https://doi.org/10.1007/s10461-021-03271-3 10.1097/QAD.0b013e32835cae9c 10.1186/s12981-020-00279-y 10.1371/journal.pone.0211252 10.1016/S1575-0973(01)70014-1 10.1111/j.1360-0443.2011.03759.x 10.1016/S2352-3018(14)70001-3 10.1089/apc.2017.0263 10.3389/fmicb.2015.00690 10.3109/16066350902770433 10.1080/10826080802484702 10.1186/s12954-017-0143-4 10.1093/jurban/jtg127 10.1016/j.drugalcdep.2017.08.036 10.1093/eurpub/ckp091 10.1111/hiv.12574 10.1097/01.aids.0000180794.27896.fb 10.1177/003335490612100205 10.1007/s10461-008-9403-3 10.2105/AJPH.2005.072249 10.1136/sextrans-2013-051195 10.1136/bmjopen-2016-014105 10.1016/j.drugalcdep.2007.11.010 10.1186/s12889-019-7747-4 10.1097/00126334-200107010-00006 10.1097/00002030-200203290-00012 10.1097/QAD.0b013e3282f3cc21 10.1016/S2352-3018(20)30202-2 10.1371/journal.pone.0084276 10.1080/09540121.2012.672718 10.1007/s10461-013-0463-7 10.1089/apc.2007.0122 10.1136/sti.79.1.59 10.1037/0278-6133.19.2.124 10.1089/108729104323076025 10.1023/b:ejep.0000032353.03967.ef 10.1007/s10461-008-9489-7 10.1007/s10461-016-1297-x 10.1097/ADM.0000000000000403 10.1037/hea0000207 10.1111/hiv.12690 10.1016/j.addbeh.2012.09.005 10.1177/0706743716664884 10.1371/journal.pone.0195185 10.1111/add.14892 10.1186/PREACCEPT-1453408941291432 10.1007/s40271-013-0009-0 10.1017/s0033291700021644 10.1016/j.medcli.2013.02.037 10.1038/s41598-018-26413-5 10.1136/sextrans-2019-054040 10.1186/s12889-019-7747-4 10.1136/postgradmedj-2012-131428 10.1080/09540121.2017.1327646 10.1016/S2352-3018(15)00018-1 10.1097/00002030-200106150-00015 10.1086/650537 10.1007/s10865-020-00148-z 10.1086/377558 10.1016/s0376-8716(00)00228-3 10.1016/j.drugpo.2016.01.017 10.1186/1471-2458-8-405 10.1001/jama.285.18.2355 10.1097/00126334-200311010-00012
AIDS and Behavior; Castro-Granell V, Garin N et. al.

May 1st, 2021 - We analysed the impact of recreational drug use (RDU) on different outcomes in people living with HIV (PLHIV). A multicentre retrospective cohort study was performed with two cohorts of PLHIV included: people using recreational drugs (PURD) vs. pe...

see more →

News  213 results

Pediatric TB – More Work Needed, Especially With HIV Coinfection
https://www.medscape.com/viewarticle/947195

Mar 9th, 2021 - Despite recent advances in the diagnosis, treatment, and prevention of pediatric tuberculosis in children living with HIV (CLHIV) and HIV-exposed uninfected children (HEU), several unmet needs remain, including studies evaluating the feasibility o...

Glycine/N-Acetylcysteine Supplementation May Slow HIV-Related Premature Aging
https://www.staging.medscape.com/viewarticle/939592

Oct 22nd, 2020 - NEW YORK (Reuters Health) - Supplementation with glycine and N-acetylcysteine (GlyNAC) appears to slow premature aging in people living with HIV (PWH), according to results from a pilot open-label clinical trial. "Supplementing GlyNAC is a highly ...

Glycine/N-Acetylcysteine Supplementation May Slow HIV-Related Premature Aging
https://www.medscape.com/viewarticle/939592

Oct 22nd, 2020 - NEW YORK (Reuters Health) - Supplementation with glycine and N-acetylcysteine (GlyNAC) appears to slow premature aging in people living with HIV (PWH), according to results from a pilot open-label clinical trial. "Supplementing GlyNAC is a highly ...

Updated Guideline on HIV Post-exposure Prophylaxis Out for Consultation
https://www.medscape.com/viewarticle/939487

Oct 20th, 2020 - The British Association for Sexual Health and HIV (BASHH) is updating its 2015 guidelines on HIV Post-Exposure Prophylaxis (PEP) Following Sexual and Occupational Exposures. The guidelines were put out for consultation in late September, with a de...

Fast Five Quiz: Antiretroviral Therapy in HIV -- When to Switch?
https://reference.medscape.com/viewarticle/924333_1

Sep 10th, 2020 - The question of when and whether to switch medications in an HIV regimen is one faced by every clinician treating patients with HIV. With more than 30 US Food and Drug Administration (FDA)-approved medicines to treat HIV infection, treatment optio...

see more →

Patient Education  9 results see all →